Lifestyle Interventions in Improving Health Outcomes and Enabling People to Live Well with Kidney Disease

被引:3
作者
Harris, Tess [1 ]
机构
[1] Polycyst Kidney Dis Int, London NW1 0SE, England
来源
KIDNEY AND DIALYSIS | 2022年 / 2卷 / 02期
关键词
CKD; kidney disease; patient reported outcomes; PROMs; lifestyle; diet; exercise; life participation; clinical practice guidelines; care pathways; PATIENT;
D O I
10.3390/kidneydial2020021
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Lifestyle interventions can play an important role in improving patients' health outcomes and helping them to live well with chronic kidney disease (CKD). The key to living well is 'life participation', defined as 'the ability to do meaningful activities of life including, but not limited to, work, study, family responsibilities, travel, sport, social, and recreational activities'. Pharmaceutical, clinical, and surgical interventions such as dialysis and transplantation can deliver beneficial health outcomes for patients. Yet CKD patients say that the focus of renal appointments is 'bloods, urine, blood pressure and kidney function' and their treatment. Little time is provided to discuss non-clinical symptoms or concerns and recommend other treatments, such as lifestyle interventions. There are no highly ranked evidence-based guidelines for lifestyle interventions in CKD due to a historic lack of evidence. Diet advice, for example, is widely requested by patients on the internet and online forums but access to reliable information is highly variable. The lack of patient reported outcome measures (PROMs) is a barrier to monitoring and gathering evidence, but regulatory changes and the efforts of international organisations should soon deliver validated tools for research and guidelines which can be implemented in holistic care pathways. A global call to action to focus on lifestyle interventions is proposed.
引用
收藏
页码:204 / 208
页数:5
相关论文
共 17 条
[1]  
[Anonymous], About us
[2]  
Clinical Outcome Assessment (COA), Frequently Asked Questions
[3]  
ema, About us
[4]  
Global Action, Plan on Physical Activity 2018-2030: More Active People for a Healthier World
[5]   Patient and Caregiver Priorities for Outcomes in CKD: A Multinational Nominal Group Technique Study [J].
Gonzalez, Andrea Matus ;
Gutman, Talia ;
Lopez-Vargas, Pamela ;
Anumudu, Samaya ;
Arce, Cristina M. ;
Craig, Jonathan C. ;
Dunn, Louese ;
Eckardt, Kai-Uwe ;
Harris, Tess ;
Levey, Andrew S. ;
Lightstone, Liz ;
Scholes-Robertson, Nicole ;
Shen, Jenny, I ;
Teixeira-Pinto, Armando ;
Wheeler, David C. ;
White, Dave ;
Wilkie, Martin ;
Jadoul, Michel ;
Winkelmayer, Wolfgang C. ;
Tong, Allison .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 76 (05) :679-689
[6]  
Group KDIGOKCW., 2013, KIDNEY INT SUPPL, V3, P1
[7]   Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review [J].
Hsu, Chia-Yu ;
Chen, Li-Ru ;
Chen, Kuo-Hu .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (18) :1-24
[8]  
IDF, Clinical Practice Recommendations for Managing Type 2 Diabetes in Primary Care
[9]   Establishing a Core Outcome Measure for Life Participation: A Standardized Outcomes in Nephrology-kidney Transplantation Consensus Workshop Report [J].
Ju, Angela ;
Josephson, Michelle A. ;
Butt, Zeeshan ;
Jowsey-Gregoire, Sheila ;
Tan, Jane ;
Taylor, Quinetta ;
Fowler, Kevin ;
Dobbels, Fabienne ;
Caskey, Fergus ;
Jha, Vivekanand ;
Locke, Jayme ;
Knoll, Greg ;
Ahn, Curie ;
Hanson, Camilla S. ;
Sautenet, Benedicte ;
Manera, Karine ;
Craig, Jonathan C. ;
Howell, Martin ;
Rutherford, Claudia ;
Tong, Allison .
TRANSPLANTATION, 2019, 103 (06) :1199-1205
[10]   Patient-centred approaches for the management of unpleasant symptoms in kidney disease [J].
Kalantar-Zadeh, Kamyar ;
Lockwood, Mark B. ;
Rhee, Connie M. ;
Tantisattamo, Ekamol ;
Andreoli, Sharon ;
Balducci, Alessandro ;
Laffin, Paul ;
Harris, Tess ;
Knight, Richard ;
Kumaraswami, Latha ;
Liakopoulos, Vassilios ;
Lui, Siu-Fai ;
Kumar, Sajay ;
Ng, Maggie ;
Saadi, Gamal ;
Ulasi, Ifeoma ;
Tong, Allison ;
Li, Philip Kam-Tao .
NATURE REVIEWS NEPHROLOGY, 2022, 18 (03) :185-198